Wellington Management Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.4M Buy
2,558,285
+521,899
+26% +$19.3M 0.02% 592
2025
Q4
$85.7M Sell
2,036,386
-1,336,838
-40% -$53.9M 0.02% 585
2025
Q3
$116M Sell
3,373,224
-100,548
-3% -$2.88M 0.02% 526
2025
Q2
$93.9M Sell
3,473,772
-379,349
-10% -$11M 0.02% 537
2025
Q1
$114M Sell
3,853,121
-231,438
-6% -$8.82M 0.02% 474
2024
Q4
$162M Sell
4,084,559
-148,285
-4% -$5.61M 0.03% 422
2024
Q3
$144M Sell
4,232,844
-2,643,340
-38% -$74.4M 0.03% 456
2024
Q2
$149M Sell
6,876,184
-491,279
-7% -$10.3M 0.03% 450
2024
Q1
$163M Buy
7,367,463
+299,028
+4% +$7.3M 0.03% 436
2023
Q4
$194M Buy
7,068,435
+571
+0% +$13.8K 0.04% 402
2023
Q3
$158M Sell
7,067,864
-104,556
-1% -$2.69M 0.03% 425
2023
Q2
$183M Buy
7,172,420
+23,342
+0.3% +$566K 0.03% 410
2023
Q1
$159M Buy
7,149,078
+512,535
+8% +$12.4M 0.03% 438
2022
Q4
$157M Buy
6,636,543
+775,820
+13% +$18M 0.03% 433
2022
Q3
$97.3M Buy
5,860,723
+8,810
+0.2% +$198K 0.02% 521
2022
Q2
$116M Buy
5,851,913
+938,918
+19% +$19M 0.02% 502
2022
Q1
$135M Sell
4,912,995
-165,832
-3% -$4.74M 0.02% 519
2021
Q4
$209M Buy
5,078,827
+9,476
+0.2% +$419K 0.03% 431
2021
Q3
$235M Buy
5,069,351
+2,319,050
+84% +$101M 0.04% 402
2021
Q2
$110M Buy
2,750,301
+642,159
+30% +$27.5M 0.02% 604
2021
Q1
$113M Sell
2,108,142
-575,928
-21% -$33.2M 0.02% 575
2020
Q4
$131M Sell
2,684,070
-1,510,099
-36% -$70M 0.02% 517
2020
Q3
$136M Buy
4,194,169
+2,106,167
+101% +$66.9M 0.03% 456
2020
Q2
$54.1M Buy
2,088,002
+1,116,200
+115% +$27.8M 0.01% 685
2020
Q1
$23.6M Buy
971,802
+200,699
+26% +$5.05M 0.01% 839
2019
Q4
$21.5M Sell
771,103
-276,384
-26% -$7.15M ﹤0.01% 963
2019
Q3
$25.1M Buy
+1,047,487
New +$27.9M 0.01% 904

Other funds holding VCYT

Wellington Management Group's VCYT Position: Q1 2026 in Review

Wellington Management Group increased its Veracyte (VCYT) stake by 26% in Q1 2026, buying an estimated $19.3M and bringing the position to 2,558,285 shares worth $82.4M. The position accounts for 0.02% of the portfolio, ranked #592.

Wellington Management Group first reported a position in VCYT in Q3 2019 and has held it in 27 quarters since. The position peaked at $235M in Q3 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Wellington Management Group held 2,558,285 shares of Veracyte worth $82.4M as of Q1 2026.
  • Wellington Management Group bought 521,899 Veracyte shares in Q1 2026, an estimated $19.3M.
  • Veracyte made up 0.02% of Wellington Management Group's portfolio in Q1 2026, its #592 holding.
  • Wellington Management Group first reported a position in Veracyte in Q3 2019 and has held it in 27 quarters since.
  • Wellington Management Group's Veracyte position peaked at $235M in Q3 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.